ReviewJournal of thoracic disease2026
Surgical stabilization of rib fractures in adults without flail chest: a scoping review of pain, quality of life, and clinical outcomes.
Review in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Rib fractures are common after blunt thoracic trauma and cause severe pain, impaired ventilation, and pulmonary complications. Surgical stabilization of rib fractures (SSRF) is established for flail chest, but its role in non-flail patients remains uncertain, with heterogeneous patient selection, timing, and outcomes. This scoping review aimed to map the extent, nature, and gaps of the evidence on SSRF in adults with acute non-flail rib fractures, focusing on pain, quality of life, complications, and hospital resource use. Methods: Following Joanna Briggs Institute methodology and the PRISMA extension for Scoping Reviews (PRISMA-ScR), we searched MEDLINE, Embase, Cochrane CENTRAL, LILACS, ClinicalTrials.gov, OSF Registries, and OpenGrey/Google Scholar from inception to 1 June 2026, without date or language restriction. Mixed studies were eligible only when non-flail data were separately extractable; others were treated as indirect evidence. Two reviewers independently screened, charted in duplicate, and appraised all studies. Results: Eleven studies were included: one randomized controlled trial (SOFRIB, n=236), one hybrid randomized/preference trial (NONFLAIL, n=110), eight cohort studies, and one single-arm series. NONFLAIL showed significantly lower pain scores with surgery at 2, 4, and 8 weeks; other studies showed a time-dependent pattern: worse pain immediately postoperatively but better pain at discharge or follow-up. Validated quality of life and pain-impact instruments were used in a minority of studies, with mixed results. Length of stay was generally longer with surgery. In SOFRIB, intensive-care-unit stay did not differ (P=0.17), whereas hospital stay was longer (+3.3 days) and pneumonia more frequent (11.4% Conclusions: The evidence is limited, heterogeneous, and dominated by observational designs, complemented by one controlled and one randomized trial. The most consistent signal concerns follow-up pain, whereas in-hospital resource use is unfavorable and quality of life mixed; these directions reflect consistency rather than established benefit. Adequately powered randomized trials using validated, time-resolved outcomes remain needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.